Form 8-K - Current report:
SEC Accession No. 0001193125-14-367933
Filing Date
2014-10-09
Accepted
2014-10-09 17:15:39
Documents
6
Period of Report
2014-10-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d803058d8k.htm 8-K 25635
2 EX-10.1 d803058dex101.htm EX-10.1 15732
3 EX-10.2 d803058dex102.htm EX-10.2 25413
4 EX-10.3 d803058dex103.htm EX-10.3 28570
5 GRAPHIC g803058exb_pg001.jpg GRAPHIC 9512
6 GRAPHIC g803058exc_pg06b.jpg GRAPHIC 10790
  Complete submission text file 0001193125-14-367933.txt   124862
Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108
MYRIAD GENETICS INC (Filer) CIK: 0000899923 (see all company filings)

EIN.: 870494517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26642 | Film No.: 141150695
SIC: 2835 In Vitro & In Vivo Diagnostic Substances